Plinabulin in Combination With Radiation/Immunotherapy in Patients With Select Advanced Cancers After Progression on PD-1 or PD-L1 Targeted Antibodies
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
University of Kansas Medical Center
City of Hope Medical Center
NantCell, Inc.
Tempus AI
Incyte Corporation
National Institutes of Health Clinical Center (CC)
Trishula Therapeutics, Inc.
Institut Bergonié
University of Washington
NRG Oncology
University of Washington
Elevation Oncology
University of Washington
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
VA Office of Research and Development
Pfizer
NextCure, Inc.
Rutgers, The State University of New Jersey
pharmaand GmbH
Fred Hutchinson Cancer Center
Revolution Medicines, Inc.
Alliance for Clinical Trials in Oncology
Pfizer
National Institutes of Health Clinical Center (CC)
Incyte Corporation
Wake Forest University Health Sciences
Wake Forest University Health Sciences
Seagen Inc.
Institut Bergonié
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
InSightec
Barbara Ann Karmanos Cancer Institute
InSightec
University of Miami
Dartmouth-Hitchcock Medical Center
University of Kentucky
University of Washington
Stanford University
Amgen
Masonic Cancer Center, University of Minnesota
University of Kansas Medical Center
GlaxoSmithKline
Roswell Park Cancer Institute
Amgen
National Institutes of Health Clinical Center (CC)
Fox Chase Cancer Center
Memorial Sloan Kettering Cancer Center
Baylor College of Medicine